RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-968
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_1003900; Gene model (P.falciparum): PF3D7_0406200; Gene product: sexual stage-specific protein precursor (Pfs16)
Phenotype Oocyst;
Last modified: 14 December 2018, 11:10
  *RMgm-968
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption
Reference (PubMed-PMID number) Reference 1 (PMID number) : 29307698
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 2.34
Other information parent lineP. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943).
The mutant parasite was generated by
Name PI/ResearcherDeligianni, E; Siden-Kiamos, I.
Name Group/DepartmentInstitute of Molecular Biology and Biotechnology
Name InstituteFORTH
CityHeraklion
CountryGreece
Name of the mutant parasite
RMgm numberRMgm-968
Principal name100390KO
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystSee 'Additional remarks phenotype'
SporozoiteNot different from wild type
Liver stageNot different from wild type
Additional remarks phenotype

Mutant/mutation
In the mutant the PBANKA_1003900  gene has been deleted using a PlasoGem DNA-construct.
This gene is a 'syntenic ortholog' of sexual stage-specific protein precursor (Pfs16; PF3D7_0406200) of P. falciparum. The similarity of P. falciparum Pfs16 and the syntenic P. berghei gene (Pbs16?) is below threshold.

Gametocytemia was similar in the mutant clones compared to WT and the morphology of male and female gametocytes was normal. There was no difference in number of males exflagellating. Nor could we detect any difference in the events of exflagellation as observed under the microscope. Ookinete conversion was also normal.
When mosquitoes were fed on mice infected with the mutant parasites lacking PBANKA_1003900 there was a reduction in the number of oocysts. In two experiments where oocyst numbers were low there was a significant difference. In the third experiment where the numbers of oocysts were very high the mutant still produced fewer oocysts but the difference was not statistically significant. These results indicate a role of the protein in ookinete-to-oocyst transformation or in early oocyst development. The oocysts produced viable and infectious sporozoites, as transmission to mice was similar to WT; infections were detected on day five after feeding in three independent experiments (one experiment each for clone 1 from the first transfection and clones 3 and 4 from the second transfection).
See RMgm- 971 for mutants expressing (C-terminally) tagged forms of PBANKA_1003900


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1003900
Gene Model P. falciparum ortholog PF3D7_0406200
Gene productsexual stage-specific protein precursor
Gene product: Alternative namePfs16
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedYes
Name of PlasmoGEM construct/vector95539
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationSee the PlasmoGem website for details of the DNA construct
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6